Home › Growth › CJC-1295 No DAC (10mg)
Growth Research Peptide
GHRH analogue · Modified GRF 1-29 · Research-grade, Australia
In stock · dispatched Australia-wide
View & buy on store →CJC-1295 No DAC, also known as Modified GRF 1-29, is a synthetic analogue of growth hormone-releasing hormone (GHRH) comprising the first 29 amino acids of the endogenous hormone, with four amino-acid substitutions that improve stability against enzymatic degradation. Without the Drug Affinity Complex (DAC), its half-life is short, which in research models produces a pulsatile rather than sustained pattern of GH release.
This 10mg presentation is the larger of the two we offer and is intended for extended laboratory study protocols. It is supplied by Vital Research Labs strictly as a reference compound for in-vitro laboratory investigation.
| Compound | CJC-1295 without DAC |
|---|---|
| Synonyms | Modified GRF 1-29, Mod GRF 1-29, CJC-1295 DAC-free |
| Category | Growth |
| CAS Number | 863288-34-0 |
| Length | 29 amino acids |
| Form | Lyophilised powder |
| Appearance | White to off-white solid |
| Quantity | 10 mg per vial |
| Purity | N/A — Certificate of Analysis pending |
| Analytical methods | HPLC (purity), mass spectrometry (identity) |
| Solubility (research) | Reconstitutes in bacteriostatic or sterile water |
Batch-specific analytical values will be recorded on the Certificate of Analysis for this batch, which is pending.
CJC-1295 No DAC is supplied as a lyophilised (freeze-dried) powder. For research handling it is typically reconstituted with bacteriostatic water; the exact volume depends on the concentration a given research protocol calls for. Our reconstitution calculator can be used to work out volumes for a target research concentration. Handle under appropriate laboratory conditions and avoid repeated freeze–thaw cycles of the reconstituted solution.
Every batch supplied by Vital Research Labs is analysed by an independent third-party laboratory, with purity confirmed by HPLC and identity by mass spectrometry. Testing for this batch is currently in progress; the Certificate of Analysis will be published in our CoA library once received. We do not publish purity figures we cannot evidence.
CJC-1295 No DAC is dispatched from within Australia to Australian research customers, packaged discreetly and appropriately for a lyophilised research compound. Orders are processed on receipt of payment via bank transfer.
The compound is identical; only the quantity of lyophilised powder per vial differs. The 10mg presentation is intended for extended research protocols requiring more material, and offers a lower cost per milligram.
DAC stands for Drug Affinity Complex, a modification that greatly extends the compound's half-life. CJC-1295 No DAC omits it, so the compound is cleared quickly. In research models this produces a pulsatile rather than sustained pattern of GH release.
Yes. CJC-1295 without DAC and Modified GRF 1-29 (Mod GRF 1-29) refer to the same compound: a 29-amino-acid GHRH analogue with substitutions that improve stability.
Testing for this batch is currently in progress. Purity is shown as N/A until the Certificate of Analysis is received, at which point it is published in our CoA library. We do not publish purity figures we cannot evidence.
The lyophilised powder is stored at -20 degrees C, protected from light and moisture. Once reconstituted for research it is kept at 2-8 degrees C and typically used within 28 days.
No. It is intended strictly for in-vitro laboratory research and development. It is not a medicine or therapeutic good and is not for human consumption, veterinary use, or clinical application.